Advanced Elementary...
Consumer Goods: Consumer Non-Durables
Carlisle Companies Inc. (CSL: NYSE)
$65.58 -0.92 | -1.38%
06/19/13 - 04:06 PM ET
Portfolios with CSL
- Portfolio NameUser Type
- ContributorTop-Rated Industrial Conglo...
- ContributorDividend Stocks for the Wee...
- UserTop Dividend Increasers for...
- Usermarkinhi Portfolio 1
- UserCGIC
- Userazhester Portfolio 1
- UserRich's Gems
- UserBarron's Interview With Nic...
- Userc bgvm 1848
- UserStreet Legal
Latest CSL Headlines from TheStreet
- 5 Stocks Going Ex-Dividend Tomorrow: AFT, TNH, CSL, HBI, PSX 05.15.13 | 10:05 am
- Carlisle Companies About To Put More Money In Your Pocket (CSL) 05.14.13 | 01:05 pm
- 3 Consumer Non-Durables Stocks Driving The Industry Higher 03.18.13 | 01:03 pm
- Carlisle Companies' CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.24.12 | 09:07 am
- Carlisle Companies Inc. (CSL): Today's Featured Consumer Non-Durables Loser 06.22.12 | 05:06 pm
- Carlisle Companies Stock To Go Ex-dividend Monday (CSL) 05.18.12 | 10:05 am
- Ex-Dividend Stocks: Valero Energy, Mattel 05.18.12 | 05:05 am
- Carlisle Companies Reaches New 52-Week High (CSL) 05.01.12 | 02:05 pm
- Analysts' Actions: AAPL, AXE, PNRA, DD 04.25.12 | 08:04 am
- Carlisle Companies' CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.24.12 | 02:04 pm
Press Releases for CSL
- CSL Behring Doses First Patient In Part 3 Of Global Phase I/III Pivotal Study Of RVIII-SingleChain (Recombinant Single-Chain Factor VIII) For Treatment Of Hemophilia A - PR Newswire 06.04.13 | 09:06 am
- CSL Behring Receives FDA Approval Of Kcentraâ¿¢ For Urgent Warfarin Reversal In Patients With Acute Major Bleeding - PR Newswire 04.30.13 | 10:04 am
- CSL Behring Donates Medicine Used In Treating Bleeding Disorders To World Federation Of Hemophilia - PR Newswire 04.03.13 | 08:04 am
- CSL Behring Receives FDA Approval To Expand The Indication For Corifact® - PR Newswire 02.28.13 | 09:02 am
- Carlisle Companies Reports $0.74 Earnings Per Share From Continuing Operations For The Fourth Quarter; Earnings Per Share Includes Charges Of $0.08 For Pension And Business Development - Business Wire 02.08.13 | 06:02 am
- Carlisle Companies Declares Regular Quarterly Dividend – Revised Record Date Of 2-19-2013 - Business Wire 02.06.13 | 01:02 pm
- Carlisle Companies Declares Regular Quarterly Dividend - Business Wire 02.06.13 | 09:02 am
- New Analysis Confirms Albumin Preserves Kidney Function And Improves Survival In Common Abdominal Infection Of Liver Disease - PR Newswire 01.21.13 | 09:01 am
- CSL Behring Enrolls First Patient In Global Pediatric Phase III Pivotal Study Of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) To Treat Hemophilia B - PR Newswire 01.21.13 | 09:01 am
- Carlisle Companies To Announce 4th Quarter Earnings On February 8, 2013 - Business Wire 01.15.13 | 08:01 am
Partner Headlines for CSL
- Carlisle Companies Incorporated (CSL) Ex-Dividend Date Scheduled for May 16, 2013 - NASDAQ 05.15.13 | 01:05 pm
- Carlisle Companies Earnings Preview: Get Ahead of the Analysts - Wall St. Cheat Sheet 04.23.13 | 01:04 pm
- General Electric (GE): Today's Most Compelling Stock Buy - NASDAQ 04.02.13 | 05:04 pm
- Carlisle Companies Incorporated (CSL) Ex-Dividend Date Scheduled for February 14, 2013 - NASDAQ 02.12.13 | 02:02 pm
- Dividend Champions Smackdown XXXI - Seeking Alpha 10.06.12 | 12:10 am
- Australian Stock Market Report – Afternoon 9/11/2012 - NASDAQ 09.11.12 | 09:09 am
- Stocks Lose More Ground; Apple Reports After Close - Investor's Business Daily 07.24.12 | 03:07 pm
- Will Carlisle See Breakout Year On Industrials? - Investor's Business Daily 07.12.12 | 02:07 pm
- Four Top Stocks With Big Earnings Estimates - Investor's Business Daily 07.05.12 | 05:07 pm
- Carlisle Keeps Its Focus On U.S. And Niche Markets - Investor's Business Daily 06.27.12 | 05:06 pm
